Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plocabulin + Gemcitabine in Advanced Solid Tumors
NCT02533674Phase 1Completed
- Sponsor
- PharmaMar
- Start
- Dec 2014
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 1, open-label, single-arm trial of plocabulin in solid tumor, sponsored by PharmaMar. Primary endpoint: Dose Limiting Toxicities at 3 weeks. Started Dec 2014; status: completed.
02
Drugs
plocabulin
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT02533674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02533674.